
Dermoscopic Accuracy for Diagnosing Acral Lentiginous Melanoma
Acral lentiginous melanoma (ALM) represents the most common melanoma subtype in Indian and other non-Caucasian populations. Because these lesions often mimic benign acral nevi, clinicians must rely on specific diagnostic tools for early detection. A new study in JAMA Dermatology confirms that the parallel ridge pattern is the most sensitive and specific dermoscopic feature for identifying this aggressive malignancy. This systematic review and meta-analysis evaluated over 9,600 lesions to establish definitive diagnostic criteria.
Identifying the Parallel Ridge Pattern
The study highlights a stark contrast between malignant and benign pigmentation. Moreover, the parallel ridge pattern showed a sensitivity of 79.6% and an exceptionally high specificity of 99.4% for ALM. In contrast, benign nevi typically exhibit a parallel furrow or latticelike pattern. Consequently, observing pigment on the ridges rather than the furrows serves as a critical red flag for clinicians during physical examinations.
Clinical Significance of Parallel Ridge Pattern in Diagnosis
Additionally, the multicomponent pattern emerged as another strong indicator of malignancy in the analyzed cohorts. Furthermore, the meta-analysis found that benign patterns, such as the parallel furrow pattern, were present in 43.1% of nevi. Therefore, dermatologists should prioritize these features when examining pigmented lesions on the palms or soles. Notably, using dermoscopy effectively reduces the need for unnecessary biopsies while ensuring timely intervention.
Improving Patient Outcomes
In the Indian clinical context, ALM often presents at advanced stages due to late recognition and diagnostic delays. Because the parallel ridge pattern is so specific, its presence should prompt immediate histopathological confirmation. However, clinicians must also remain vigilant for atypical presentations that may lack these classic markers. Similarly, integrating these dermoscopic findings into routine screenings can significantly improve survival rates for patients with acral malignancies.
Frequently Asked Questions
What is the most reliable dermoscopic sign of acral melanoma?
The most reliable sign is the parallel ridge pattern, which occurs when pigmentation occupies the ridges of the skin markings rather than the furrows. It has a specificity of over 99% for acral lentiginous melanoma.
Can benign nevi show a parallel ridge pattern?
While extremely rare, only about 0.6% of benign acral nevi exhibit this pattern. Most benign lesions show a parallel furrow, latticelike, or fibrillar pattern instead.
Why is early diagnosis of ALM critical?
Acral lentiginous melanoma is an aggressive subtype that often goes unnoticed until it reaches an advanced stage. Early detection through dermoscopy is essential for improving prognosis and reducing morbidity.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
- Okwara CJ et al. Diagnostic Accuracy of Dermoscopic Features in Acral Lentiginous Melanoma: A Systematic Review and Meta-analysis. JAMA Dermatol. 2026 Mar 11. doi: 10.1001/jamadermatol.2026.0071. PMID: 41811312.
- Saida T, Koga H, Uhara H. Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol. 2011 Jan;38(1):25-34. doi: 10.1111/j.1346-8138.2010.01174.x.
- Tan A, Stein JA. Dermoscopic patterns of acral melanocytic lesions in skin of color. Cutis. 2019 May;103(5):274-276.

More from MedShots Daily

Comprehensive meta-analysis identifies the parallel ridge pattern as the most accurate dermoscopic indicator for diagnosing acral lentiginous melanoma....
2 months ago

Procizumab is a humanized antibody that neutralizes circulating DPP3, a biological driver of shock, by preventing angiotensin II degradation....
Today

India offers technical support and proven digital public health solutions to advance maternal and child health outcomes globally....
Today

India is launching a national registry to track implantable medical devices and patients, enhancing accountability and safety during global product recalls....
Today

Medtronic has announced its plans to acquire SPR Therapeutics for $650 million, expanding its non-opioid, minimally invasive chronic pain treatments....
Today

Research highlights sex-specific roles of oxytocin neurons in the hypothalamus and signaling in the nucleus accumbens regarding juvenile social play behavio...
Today